US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
CTMX holding history
CytomX Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −7,392−100.0% | Sold out | Holders |
| Q1 2025 | 7,392 | $4.70K | <0.1% | −23,400−76.0% | Reduced | Holders |
| Q4 2024 | 30,792 | $31.7K | <0.1% | −3,000−8.9% | Reduced | Holders |
| Q3 2024 | 33,792 | $39.9K | <0.1% | +33,792 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −50−100.0% | Sold out | Holders |
| Q4 2021 | 50 | $0 | 0.0% | +50 | New | Holders |